BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20498288)

  • 61. [Role of target controlled infusion of remifentanil for the prevention of etomidate induced myoclonus during general anesthesia].
    Zou L; Yuan H; Wang HY; Geng ZY; Xu L; Sun L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):112-5. PubMed ID: 23599979
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Butorphanol pre-treatment prevents myoclonus induced by etomidate: a randomised, double-blind, controlled clinical trial.
    He L; Ding Y; Chen H; Qian Y; Li Z
    Swiss Med Wkly; 2014; 144():w14042. PubMed ID: 25317545
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of etomidate on bispectral index scale and spectral entropy during induction of anesthesia by means of the raw electroencephalographic and electromyographic characteristics.
    Kim HM; Shin SW; Yoon JY; Lee HJ; Kim KH; Baik SW
    Korean J Anesthesiol; 2012 Mar; 62(3):230-3. PubMed ID: 22474548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sedation during spinal anesthesia.
    Pollock JE; Neal JM; Liu SS; Burkhead D; Polissar N
    Anesthesiology; 2000 Sep; 93(3):728-34. PubMed ID: 10969306
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate.
    Lv Z; Fang J; Zhu J; Liang B; Li F; Jiang S; Li A; Cheng Z; Dong T
    J Anesth; 2014 Dec; 28(6):944-7. PubMed ID: 24828848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The etomidate requirement is decreased in patients with obstructive jaundice.
    Song JC; Sun YM; Zhang MZ; Yang LQ; Tao TZ; Yu WF
    Anesth Analg; 2011 Nov; 113(5):1028-32. PubMed ID: 21865492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease.
    Su F; El-Komy MH; Hammer GB; Frymoyer A; Cohane CA; Drover DR
    Biopharm Drug Dispos; 2015 Mar; 36(2):104-14. PubMed ID: 25377074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part II. Pharmacodynamics of Electroencephalogram Effects.
    Eisenried A; Schüttler J; Lerch M; Ihmsen H; Jeleazcov C
    Anesthesiology; 2020 Apr; 132(4):652-666. PubMed ID: 31972657
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myoclonus after prolonged infusion of etomidate treated with dantrolene.
    Greenberg M; Hilty C
    J Clin Anesth; 2003 Sep; 15(6):489-90. PubMed ID: 14652121
    [No Abstract]   [Full Text] [Related]  

  • 70. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
    Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
    Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Unrepaired Tetralogy of Fallot-related Pathophysiologic Changes Reduce Systemic Clearance of Etomidate in Children.
    Shen Y; Cai MH; Ji W; Bai J; Huang Y; Sun Y; Lin L; Niu J; Zhang MZ
    Anesth Analg; 2016 Sep; 123(3):722-30. PubMed ID: 27537760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxycodone for prevention of etomidate-induced myoclonus: a randomized double-blind controlled trial.
    Wang W; Lv J; Wang Q; Yang L; Yu W
    J Int Med Res; 2018 May; 46(5):1839-1845. PubMed ID: 29536782
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Buccal absorption of etomidate from a solid formulation in dogs.
    Zhang J; Maland L; Hague B; Niu S; Robertson S; Coleman D; Stanley TH; Streisand JB
    Anesth Analg; 1998 May; 86(5):1116-22. PubMed ID: 9585308
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pharmacokinetics of continuous infusion of etomidate in cirrhotic patients].
    Bonnardot JP; Levron JC; Deslauriers M; Brule ML; Flaisler B; Deligne P
    Ann Fr Anesth Reanim; 1991; 10(5):443-9. PubMed ID: 1755554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.
    Hannivoort LN; Eleveld DJ; Proost JH; Reyntjens KM; Absalom AR; Vereecke HE; Struys MM
    Anesthesiology; 2015 Aug; 123(2):357-67. PubMed ID: 26068206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between etomidate plasma concentration and EEG effect in the rat.
    De Paepe P; Van Hoey G; Belpaire FM; Rosseel MT; Boon PA; Buylaert WA
    Pharm Res; 1999 Jun; 16(6):924-9. PubMed ID: 10397615
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects.
    Zhou Y; Hu P; Huang Y; Nuoer S; Song K; Wang H; Wen J; Jiang J; Chen X
    Front Pharmacol; 2018; 9():1316. PubMed ID: 30510509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epileptic seizure during anaesthesia induction with etomidate.
    Sen H; Algul A; Senol MG; Ates A; Kilic E; Ozkan S; Dagli G
    Middle East J Anaesthesiol; 2010 Jun; 20(5):723-5. PubMed ID: 20803863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Distribution of etomidate in a fatal intoxication.
    Molina DK; Hargrove VM; Rodriguez RG
    J Anal Toxicol; 2008 Oct; 32(8):715-8. PubMed ID: 19007527
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimization, and
    Geng D; Li Y; Wang C; Ren B; Wang H; Wu C; Zhang Y; Zhao L; Zhao L
    Drug Deliv; 2021 Dec; 28(1):873-883. PubMed ID: 33960250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.